NeuPath Health Inc (NPTH) - Net Assets
Based on the latest financial reports, NeuPath Health Inc (NPTH) has net assets worth CA$20.95 Million CAD (≈ $15.16 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$45.09 Million ≈ $32.62 Million USD) and total liabilities (CA$24.14 Million ≈ $17.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read NPTH current and long-term liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$20.95 Million |
| % of Total Assets | 46.46% |
| Annual Growth Rate | 13.55% |
| 5-Year Change | -18.89% |
| 10-Year Change | N/A |
| Growth Volatility | 70.24 |
NeuPath Health Inc - Net Assets Trend (2019–2025)
This chart illustrates how NeuPath Health Inc's net assets have evolved over time, based on quarterly financial data. Also explore NeuPath Health Inc (NPTH) total assets for the complete picture of this company's asset base.
Annual Net Assets for NeuPath Health Inc (2019–2025)
The table below shows the annual net assets of NeuPath Health Inc from 2019 to 2025. For live valuation and market cap data, see NPTH market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$20.95 Million ≈ $15.16 Million |
-2.24% |
| 2024-12-31 | CA$21.43 Million ≈ $15.50 Million |
-1.86% |
| 2023-12-31 | CA$21.84 Million ≈ $15.80 Million |
+0.86% |
| 2022-12-31 | CA$21.65 Million ≈ $15.66 Million |
-16.17% |
| 2021-12-31 | CA$25.83 Million ≈ $18.69 Million |
-6.49% |
| 2020-12-31 | CA$27.62 Million ≈ $19.98 Million |
+182.71% |
| 2019-12-31 | CA$9.77 Million ≈ $7.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NeuPath Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1398400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$48.09 Million | 233.21% |
| Total Equity | CA$20.62 Million | 100.00% |
NeuPath Health Inc Competitors by Market Cap
The table below lists competitors of NeuPath Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Veto Switchgears And Cables Limited
NSE:VETO
|
$22.40 Million |
|
Silver Touch Technologies Limited
NSE:SILVERTUC
|
$22.41 Million |
|
Tontek Design Technology Ltd
TWO:5487
|
$22.44 Million |
|
OneSavings Bank PLC
LSE:OSB
|
$22.44 Million |
|
Comelf SA
RO:CMF
|
$22.40 Million |
|
M4B SA ZY 8
F:24D
|
$22.38 Million |
|
Barksdale Resources Corp
V:BRO
|
$22.38 Million |
|
NWP Holdings Bhd
KLSE:5025
|
$22.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NeuPath Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 21,404,000 to 20,619,000, a change of -785,000 (-3.7%).
- Net loss of 717,000 reduced equity.
- Share repurchases of 231,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-717.00K | -3.48% |
| Share Repurchases | CA$231.00K | -1.12% |
| Other Changes | CA$163.00K | +0.79% |
| Total Change | CA$- | -3.67% |
Book Value vs Market Value Analysis
This analysis compares NeuPath Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.50x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.60x to 1.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CA$0.34 | CA$0.55 | x |
| 2020-12-31 | CA$0.66 | CA$0.55 | x |
| 2021-12-31 | CA$0.55 | CA$0.55 | x |
| 2022-12-31 | CA$0.43 | CA$0.55 | x |
| 2023-12-31 | CA$0.39 | CA$0.55 | x |
| 2024-12-31 | CA$0.38 | CA$0.55 | x |
| 2025-12-31 | CA$0.37 | CA$0.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NeuPath Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.82%
- • Asset Turnover: 1.93x
- • Equity Multiplier: 2.19x
- Recent ROE (-3.48%) is above the historical average (-15.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -54.34% | -10.70% | 1.31x | 3.89x | CA$-6.29 Million |
| 2020 | -18.31% | -10.62% | 1.03x | 1.67x | CA$-7.82 Million |
| 2021 | -12.50% | -5.31% | 1.19x | 1.99x | CA$-5.81 Million |
| 2022 | -19.12% | -6.65% | 1.39x | 2.07x | CA$-6.34 Million |
| 2023 | -0.49% | -0.16% | 1.58x | 1.89x | CA$-2.31 Million |
| 2024 | -3.40% | -1.00% | 1.76x | 1.93x | CA$-2.87 Million |
| 2025 | -3.48% | -0.82% | 1.93x | 2.19x | CA$-2.78 Million |
Industry Comparison
This section compares NeuPath Health Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $297,679,932
- Average return on equity (ROE) among peers: -15.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NeuPath Health Inc (NPTH) | CA$20.95 Million | -54.34% | 1.15x | $22.40 Million |
| HealWELL AI Inc. (AIDX) | $123.94 Million | -37.87% | 1.30x | $201.58 Million |
| CareRx Corp (CRRX) | $-19.96 Million | 0.00% | 0.00x | $167.61 Million |
| dentalcorp Holdings Ltd (DNTL) | $1.79 Billion | -0.93% | 0.89x | $1.52 Billion |
| Medical Facilities Corporation (DR) | $114.69 Million | -3.84% | 2.29x | $218.65 Million |
| Element Lifestyle Retirement Inc (ELM) | $-590.09K | 0.00% | 0.00x | $509.83K |
| Extendicare Inc (EXE) | $658.62 Million | 9.92% | 2.37x | $2.06 Billion |
| Jack Nathan Medical Corp (JNH) | $8.52 Million | -116.33% | 0.25x | $68.71 |
| KDA Group Inc (KDA) | $-3.65 Million | 0.00% | 0.00x | $16.18 Million |
| Nova Leap Health Corp (NLH) | $9.84 Million | 12.76% | 0.78x | $24.32 Million |
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more